 Leukemia, B-Cell
"Leukemia, B-Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant disease of the B-LYMPHOCYTES in the bone marrow and/or blood.
| Descriptor ID |
D015448
|
| MeSH Number(s) |
C04.557.337.428.080 C15.604.515.560.080 C20.683.515.528.080
|
| Concept/Terms |
Leukemia, B-Cell- Leukemia, B-Cell
- Leukemia, B Cell
- Lymphocytic Leukemia, B-Cell
- B-Cell Lymphocytic Leukemia
- B-Cell Lymphocytic Leukemias
- Leukemia, B-Cell Lymphocytic
- Leukemias, B-Cell Lymphocytic
- Lymphocytic Leukemia, B Cell
- Lymphocytic Leukemias, B-Cell
- Leukemia, Lymphocytic, B Cell
- Leukemia, Lymphocytic, B-Cell
- B-Cell Leukemia
- B Cell Leukemia
- B-Cell Leukemias
- Leukemias, B-Cell
- B-Lymphocytic Leukemia
- B Lymphocytic Leukemia
- B-Lymphocytic Leukemias
- Leukemia, B-Lymphocytic
- Leukemias, B-Lymphocytic
|
Below are MeSH descriptors whose meaning is more general than "Leukemia, B-Cell".
Below are MeSH descriptors whose meaning is more specific than "Leukemia, B-Cell".
This graph shows the total number of publications written about "Leukemia, B-Cell" by people in UAMS Profiles by year, and whether "Leukemia, B-Cell" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2020 | 0 | 1 | 1 | | 2019 | 0 | 1 | 1 | | 2005 | 0 | 1 | 1 | | 2003 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Leukemia, B-Cell" by people in Profiles over the past ten years.
-
Niu A, McDougal A, Ning B, Safa F, Luk A, Mushatt DM, Nachabe A, Zwezdaryk KJ, Robinson J, Peterson T, Socola F, Safah H, Hu T, Saba NS. COVID-19 in allogeneic stem cell transplant: high false-negative probability and role of CRISPR and convalescent plasma. Bone Marrow Transplant. 2020 12; 55(12):2354-2356.
-
Duell J, Lukic DS, Karg M, Reusch U, Koch J, Zhukovsky EA, Rajkovic E, Treder M, Rasche L, Eisele F, Einsele H, Topp MS. Functionally Defective T Cells After Chemotherapy of B-Cell Malignancies Can Be Activated by the Tetravalent Bispecific CD19/CD3 Antibody AFM11. J Immunother. 2019 06; 42(5):180-188.
|
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|